Please wait
Loading...
News / Events

 - Wednesday, July 15, 2020
Media Statement 13 July 2020 For immediate release 3Sixty Biopharmaceuticals Partners with Jubilant Generics to supply Remdesivir IV in Southern Africa 3Sixty Biopharmaceuticals (Pty) Ltd (3Sxity Biopharma), a division of 3Sixty Global Solutions Group (3SixtyGSG) has partnered with Jubilant Generics, a subsidiary of Jubilant life sciences Limited to supply Remdesivir for the treatment of COVID-19 infection in Southern Africa. On the 12th May 2020, Jubilant Life Sciences entered into Licensin...